These days, a prostate-specific antigen (PSA) blood test is often the first step towards a diagnosis. ‘Men don’t always need ...
Advancements in radiomics, machine learning, and deep learning have the potential to revolutionize cancer diagnosis and treatment by enabling more precise ...
The radioligand agent is now approved for use before chemotherapy in patients who have been treated with an androgen receptor pathway inhibitor.
The FDA has expanded the approval for Pluvicto (lutetium Lu 177 vipivotide tetraxetan) to include patients with PSMA-positive mCRPC who have been treated with ARPI therapy and can delay chemotherapy.
A woman with incurable cancer has told how the disease turned her life upside down — and caused her to shrink four inches. Debbie Archer, 60, had suffered a bug bite while gardening and was trying to ...
In our modern world, chemicals play an essential role in creating products that make daily life more convenient. However, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results